The differential expression of SLC30A1, SLC30A5, SLC30A6, SLC30A9 and SLC30A10 was found to vary with tumor stage and grade and appears to be related mostly to early events in PCa development and progression. This evidence concerns the gene SLC30A6 and neoplasm.